Posts by Kerry L. Reynolds, MD
-
Researchers Chart the Course of Severe Checkpoint Inhibitor-related Colitis
Massachusetts General Hospital researchers have charted the course of severe checkpoint inhibitor–related colitis, including the fact that it usually develops within three months, and that half of the patients require second-line immunosuppression.
Biography
Dr. Kerry Reynolds is a physician at the Massachusetts General Hospital Cancer Center and Instructor of Medicine at Harvard Medical School. She currently serves as the Director of the Severe Immunotherapy Complications Service, in addition to being the Clinical Director for the inpatient cancer services at Mass General Cancer Center.
Dr. Reynolds specializes in the care of hospitalized patients. Under her leadership, the Massachusetts General Cancer Center’s inpatient program evaluates and treats over 4,000 patients each year and serves as a core training experience for Harvard Medical School students, residents, and fellows each year.
After completing her own residency, chief residency at Massachusetts General, and fellowship training in Oncology at Dana-Farber/Partners Cancer Care, she joined the Harvard Medical School faculty in 2014, where she provides clinical care, supervises and educates trainees, participates in administrative affairs, and conducts research on severe toxicities associated with novel immunotherapy agents.
Her short-term academic and primary research focus is to create a clinical database and tissue collection infrastruction to capture the full national history of immune related adverse events (irAEs), and uncover predictors that will identify patients at highest risk for adverse events associated with immunotherapy, or those destined to be refractory. The overall goal is to characterize these severe clinical presentations, understand the blueprint of cells/molecules driving these clinical presentations, and ultimately develop new therapeutics to improve the treatment of this unique patient population.
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.